1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Smith & Nephew Acquires BlueSky Medical Group

M&A Deal Summary

Smith & Nephew Acquires BlueSky Medical Group

On May 1, 2007, Smith & Nephew acquired medical products company BlueSky Medical Group for 110M USD

Acquisition Highlights
  • This is Smith & Nephew’s 8th transaction in the Medical Products sector.
  • This is Smith & Nephew’s 11th largest (disclosed) transaction.
  • This is Smith & Nephew’s 6th transaction in the United States.
  • This is Smith & Nephew’s 2nd transaction in California.

M&A Deal Summary
Date 2007-05-01
Target BlueSky Medical Group
Sector Medical Products
Buyer(s) Smith & Nephew
Deal Type Add-on Acquisition
Deal Value 110M USD

Target

BlueSky Medical Group

Carlsbad, California, United States
BlueSky, which manufactures the Versatile 1 wound vacuum system, has an estimated 5% of the global market for pumps and accessories used in negative-pressure therapy.

Search 205,333 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Smith & Nephew

Watford, United Kingdom
Category Company
Founded 1856
Sector Medical Products
Employees18,452
Revenue 5.5B USD (2023)
DESCRIPTION

Smith & Nephew is a British-based multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, United Kingdom.

DEAL STATS #
Overall 9 of 34
Sector (Medical Products) 8 of 23
Type (Add-on Acquisition) 8 of 25
State (California) 2 of 6
Country (United States) 6 of 21
Year (2007) 2 of 2
Size (of disclosed) 11 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-03-12 Plus Orthopedics Holding AG

Rotkreuz, Switzerland

PlusOrthopedics Holding AG. is a orthopedic company with over 850 employees providing implants and technically advanced surgical solutions. Plus has focused its activities on the development of implants for hips, knees, shoulders and small joints.

Buy $889M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-11-11 Nucryst Pharmaceuticals

Wakefield, Massachusetts, United States

Nucryst Pharmaceuticals, Inc. develops, manufactures and commercializes medical products that fight infection and inflammation based on its nanocrystalline silver technology.

Buy -
Mergr

Product

Company

Legal